These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23123691)

  • 21. Basal Ganglia volumes in patients with Gilles de la Tourette syndrome.
    Peterson BS; Thomas P; Kane MJ; Scahill L; Zhang H; Bronen R; King RA; Leckman JF; Staib L
    Arch Gen Psychiatry; 2003 Apr; 60(4):415-24. PubMed ID: 12695320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-, parent-, and teacher-reported behavioral symptoms in youngsters with Tourette syndrome: a case-control study.
    Termine C; Selvini C; Balottin U; Luoni C; Eddy CM; Cavanna AE
    Eur J Paediatr Neurol; 2011 Mar; 15(2):95-100. PubMed ID: 21273099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychiatric disorders and behavioral problems in children and adolescents with Tourette syndrome.
    Ghanizadeh A; Mosallaei S
    Brain Dev; 2009 Jan; 31(1):15-9. PubMed ID: 18558469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficacy of clonidine transdermal patch for treatment of Tourette's syndrome in children].
    Kang H; Zhang YF; Jiao FY; Guo XY; Gao XM
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):537-9. PubMed ID: 19650984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics of Tourette syndrome.
    Kano Y; Ohta M; Nagai Y
    Psychiatry Clin Neurosci; 1998 Feb; 52(1):51-7. PubMed ID: 9682933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tic symptom profiles in subjects with Tourette Syndrome from two genetically isolated populations.
    Mathews CA; Jang KL; Herrera LD; Lowe TL; Budman CL; Erenberg G; Naarden A; Bruun RD; Schork NJ; Freimer NB; Reus VI
    Biol Psychiatry; 2007 Feb; 61(3):292-300. PubMed ID: 16581034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonidine in the treatment of Tourette syndrome: a review of data.
    Leckman JF; Cohen DJ; Detlor J; Young JG; Harcherik D; Shaywitz BA
    Adv Neurol; 1982; 35():391-401. PubMed ID: 6756089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in Gilles de la Tourette syndrome: implications for clinical practice and future research.
    Leckman JF; Cohen DJ
    Psychiatr Dev; 1983; 1(3):301-16. PubMed ID: 6324164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychopharmacology for the clinician: management of comorbid Tourette syndrome and attention-deficit/hyperactivity disorder: are psychostimulants an option?
    Pringsheim T
    J Psychiatry Neurosci; 2012 Nov; 37(6):432. PubMed ID: 23092593
    [No Abstract]   [Full Text] [Related]  

  • 31. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of intronic variants of the BTBD9 gene with Tourette syndrome.
    Rivière JB; Xiong L; Levchenko A; St-Onge J; Gaspar C; Dion Y; Lespérance P; Tellier G; Richer F; Chouinard S; Rouleau GA;
    Arch Neurol; 2009 Oct; 66(10):1267-72. PubMed ID: 19822783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clonidine in Tourette's syndrome.
    Cohen DJ; Young JG; Nathanson JA; Shaywitz BA
    Lancet; 1979 Sep; 2(8142):551-3. PubMed ID: 89558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonidine ameliorates Gilles de la Tourette syndrome.
    Cohen DJ; Detlor J; Young JG; Shaywitz BA
    Arch Gen Psychiatry; 1980 Dec; 37(12):1350-7. PubMed ID: 6255888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding disability in Tourette syndrome.
    Pringsheim T; Lang A; Kurlan R; Pearce M; Sandor P
    Dev Med Child Neurol; 2009 Jun; 51(6):468-72. PubMed ID: 19018838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tics and Tourette syndrome: an adult perspective.
    Galvez-Jimenez N
    Cleve Clin J Med; 2012 Jul; 79 Suppl 2():S35-9. PubMed ID: 22761269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contemporary assessment and pharmacotherapy of Tourette syndrome.
    Scahill L; Erenberg G; Berlin CM; Budman C; Coffey BJ; Jankovic J; Kiessling L; King RA; Kurlan R; Lang A; Mink J; Murphy T; Zinner S; Walkup J;
    NeuroRx; 2006 Apr; 3(2):192-206. PubMed ID: 16554257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clonidine and Gilles de la Tourette's syndrome: double-blind study using objective rating methods.
    Goetz CG; Tanner CM; Wilson RS; Carroll VS; Como PG; Shannon KM
    Ann Neurol; 1987 Mar; 21(3):307-10. PubMed ID: 3300518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of medications on regulation of body temperature of patients with Tourette syndrome.
    Kessler AR
    J Child Neurol; 2004 Mar; 19(3):220-4. PubMed ID: 15119484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome.
    Wijemanne S; Wu LJ; Jankovic J
    Mov Disord; 2014 Jan; 29(1):126-30. PubMed ID: 24150997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.